|
Improved Diagnostic and Prognostic Tools for Rheumatoid Arthritis: Unmet Needs in a Changing MarketPublished by: Decision Resources Published: Mar. 21, 2005 - 19 Pages The price of this report has been reduced due to its age. The original price was $1,900 for PDF E-mail From Publisher.Table of Contents
AbstractAccording to recent clinical studies, the key to achieving optimal outcomes in rheumatoid arthritis (RA) is to diagnose and treat it as early as possible. The need to develop more-sensitive and more-specific markers for early-stage disease is urgent. While developments in disease- modifying drugs and biologic agents have revolutionized the treatment of RA, enabling physicians to slow disease progression and prevent some joint destruction, diagnostics has lagged behind. Therefore, the challenge in this area of medicine lies almost exclusively in the diagnosis of early-stage RA, which can be accomplished only with novel serological tests, imaging techniques, or RA biomarkers. This report profiles the efforts under way by a variety of companies in this area of great unmet need.Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||